Endocrinology, Vol 134, 2044-2050, Copyright © 1994 by Endocrine Society

ARTICLES

Coculture of primary rat hepatocytes and nonparenchymal cells permits expression of insulin-like growth factor binding protein-3 in vitro

BC Villafuerte, BL Koop, CI Pao, L Gu, GG Birdsong and LS Phillips
Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30303.

In biological fluids, the insulin-like growth factors (IGFs) are associated with binding proteins (IGFBPs), which modify IGF distribution and action. Circulating IGFs are bound predominantly to IGFBP-3, of apparent hepatic origin, but regulation of IGFBP-3 has been difficult to dissect because of the lack of systems suitable for examining hepatic production of IGFBP-3 in vitro. In the present studies, IGFBP-3 expression was identified primarily in hepatic nonparenchymal cells, particularly Kupffer and sinusoidal endothelial cells. Coculture with hepatocytes enhanced the stability of nonparenchymal cells to express IGFBP-3 in vitro. IGFBP-3 in conditioned medium had apparent mol wt of 150-300 kilodaltons, suggesting formation of a ternary complex with IGFs and the acid-labile subunit. Expression and secretion of IGFBP-3 were hormonally responsive and strongly correlated (r = 0.79; P < 0.001), with 2- to 3-fold stimulation by added insulin or IGF-I (both P < 0.05), but not by added GH alone. Our findings suggest that GH may act indirectly to promote IGFBP-3 generation in vivo via increasing both the secretion of insulin and the hepatic production of IGF-I; in patients with diabetes mellitus, reduced circulating levels of IGFBP-3 despite high levels of GH may result from both insulin deficiency and inadequate hepatic production of IGF-I. Coculture of hepatic nonparenchymal and parenchymal cells should be useful for further analysis of the mechanism of IGFBP-3 regulation.

This article has been cited by other articles:

				P. F. Collett-Solberg, M. Misra, and on behalf of the Drug and Therapeutics Committee o The Role of Recombinant Human Insulin-Like Growth Factor-I in Treating Children with Short Stature J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 10 - 18. [Abstract] [Full Text] [PDF]

				B. C. Villafuerte and E. N. Kaytor An Insulin-response Element-binding Protein That Ameliorates Hyperglycemia in Diabetes J. Biol. Chem., May 20, 2005; 280(20): 20010 - 20020. [Abstract] [Full Text] [PDF]

				B. C. Villafuerte, L. S. Phillips, M. J. Rane, and W. Zhao Insulin-response Element-binding Protein 1: A NOVEL Akt SUBSTRATE INVOLVED IN TRANSCRIPTIONAL ACTION OF INSULIN J. Biol. Chem., August 27, 2004; 279(35): 36650 - 36659. [Abstract] [Full Text] [PDF]

				J.-G. Scharf, F. Dombrowski, R. Novosyadlyy, C. Eisenbach, I. Demori, B. Kubler, and T. Braulke Insulin-Like Growth Factor (IGF)-Binding Protein-1 Is Highly Induced during Acute Carbon Tetrachloride Liver Injury and Potentiates the IGF-I-Stimulated Activation of Rat Hepatic Stellate Cells Endocrinology, July 1, 2004; 145(7): 3463 - 3472. [Abstract] [Full Text] [PDF]

				J-G Scharf, F Dombrowski, and G Ramadori The IGF axis and hepatocarcinogenesis Mol. Pathol., June 1, 2001; 54(3): 138 - 144. [Abstract] [Full Text]

				C. Lassarre, F. Duron, and M. Binoux Use of the Ligand Immunofunctional Assay for Human Insulin-Like Growth Factor (IGF) Binding Protein-3 (IGFBP-3) to Analyze IGFBP-3 Proteolysis and IGF-I Bioavailability in Healthy Adults, GH-Deficient and Acromegalic Patients, and Diabetics J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1942 - 1952. [Abstract] [Full Text]

				E. M. Zimmermann, L. Li, E. C. Hoyt, J. B. Pucilowska, S. Lichtman, and P. K. Lund Cell-specific localization of insulin-like growth factor binding protein mRNAs in rat liver Am J Physiol Gastrointest Liver Physiol, March 1, 2000; 278(3): G447 - G457. [Abstract] [Full Text] [PDF]

				S. N. BHATIA, U. J. BALIS, M. L. YARMUSH, and M. TONER Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells FASEB J, November 1, 1999; 13(14): 1883 - 1900. [Abstract] [Full Text]

				C SELDEN, M KHALIL, and H J F HODGSON What keeps hepatocytes on the straight and narrow? Maintaining differentiated function in the liver Gut, April 1, 1999; 44(4): 443 - 446. [Full Text] [PDF]

				M. E. Wilson Effects of Estradiol and Exogenous Insulin-Like Growth Factor I (IGF-I) on the IGF-I Axis during Growth Hormone Inhibition and Antagonism J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4013 - 4021. [Abstract] [Full Text]

				S. Skrtic, V. Wallenius, S. Ekberg, A. Brenzel, A. M. Gressner, and J.-O. Jansson Insulin-Like Growth Factors Stimulate Expression of Hepatocyte Growth Factor But Not Transforming Growth Factor {beta}1 in Cultured Hepatic Stellate Cells Endocrinology, November 1, 1997; 138(11): 4683 - 4689. [Abstract] [Full Text] [PDF]

				M. Thoren, A. Hilding, R. C. Baxter, M. Degerblad, I.-L. Wivall-Helleryd, and K. Hall Serum Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1 and -3, and the Acid-Labile Subunit as Serum Markers of Body Composition during Growth Hormone (GH) Therapy in Adults with GH Deficiency J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 223 - 228. [Abstract] [Full Text] [PDF]